Hanmi Pharm vows to make inroads to European market

Hanmi Pharm has recently won market authorizations of its first generic antibiotic ceftazidime from the UK and Germany, following ceftriaxone and cefotaxime and vowed to push up with its plan to make quicker inroads to European market during the second quarter of this year.

The company has so far endeavored to further explore overseas markets, as part of its efforts to expand the export volu...